ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2026

Investigating Real-World Tolerance and Dose Reductions of Oncology Multikinase Inhibitors in a VA Population.

Trey Hon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.